UnitedHealth Group (NYSE:UNH) Given New $418.00 Price Target at JPMorgan Chase & Co.

UnitedHealth Group (NYSE:UNH) had its price target raised by JPMorgan Chase & Co. from $405.00 to $418.00 in a research note issued to investors on Friday,Benzinga reports. The brokerage currently has an overweight rating on the healthcare conglomerate’s stock.

Several other analysts have also recently commented on UNH. Truist Financial reiterated a “buy” rating and issued a $360.00 price target (down previously from $580.00) on shares of UnitedHealth Group in a research note on Monday, May 19th. TD Securities reiterated a “hold” rating and issued a $308.00 price target (down previously from $520.00) on shares of UnitedHealth Group in a research note on Monday, May 19th. Morgan Stanley decreased their price target on shares of UnitedHealth Group from $563.00 to $374.00 and set an “overweight” rating on the stock in a research note on Wednesday, May 14th. Hsbc Global Res cut shares of UnitedHealth Group from a “hold” rating to a “moderate sell” rating in a research note on Wednesday, May 21st. Finally, TD Cowen cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating and set a $308.00 target price on the stock. in a research report on Monday, May 19th. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating and sixteen have issued a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $427.09.

UnitedHealth Group Trading Down 1.7%

Shares of UnitedHealth Group stock opened at $302.04 on Friday. The company has a market capitalization of $273.99 billion, a P/E ratio of 12.65, a P/E/G ratio of 1.44 and a beta of 0.44. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.85 and a current ratio of 0.85. The company has a fifty day moving average of $359.15 and a 200 day moving average of $463.79. UnitedHealth Group has a fifty-two week low of $248.88 and a fifty-two week high of $630.73.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing the consensus estimate of $7.29 by ($0.09). The firm had revenue of $109.58 billion during the quarter, compared to the consensus estimate of $111.56 billion. UnitedHealth Group had a return on equity of 26.29% and a net margin of 5.39%. During the same period in the prior year, the company posted $6.91 EPS. On average, sell-side analysts anticipate that UnitedHealth Group will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th will be paid a $2.21 dividend. This is an increase from UnitedHealth Group’s previous quarterly dividend of $2.10. This represents a $8.84 dividend on an annualized basis and a yield of 2.93%. The ex-dividend date is Monday, June 16th. UnitedHealth Group’s dividend payout ratio is currently 37.02%.

Insiders Place Their Bets

In other UnitedHealth Group news, Director Timothy Patrick Flynn acquired 1,533 shares of the company’s stock in a transaction dated Wednesday, May 14th. The shares were purchased at an average cost of $320.80 per share, for a total transaction of $491,786.40. Following the completion of the purchase, the director now owns 6,033 shares in the company, valued at approximately $1,935,386.40. This trade represents a 34.07% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Director Kristen Gil acquired 3,700 shares of the company’s stock in a transaction dated Thursday, May 15th. The shares were acquired at an average price of $271.17 per share, for a total transaction of $1,003,329.00. Following the completion of the purchase, the director now owns 3,818 shares of the company’s stock, valued at approximately $1,035,327.06. This represents a 3,135.59% increase in their position. The disclosure for this purchase can be found here. Insiders have purchased 109,408 shares of company stock worth $31,607,768 in the last three months. Corporate insiders own 0.28% of the company’s stock.

Institutional Investors Weigh In On UnitedHealth Group

Several institutional investors have recently bought and sold shares of the company. Voya Investment Management LLC boosted its stake in UnitedHealth Group by 33.1% in the first quarter. Voya Investment Management LLC now owns 1,127,586 shares of the healthcare conglomerate’s stock valued at $590,463,000 after acquiring an additional 280,554 shares in the last quarter. Maple Capital Management Inc. boosted its stake in UnitedHealth Group by 1.7% in the first quarter. Maple Capital Management Inc. now owns 68,861 shares of the healthcare conglomerate’s stock valued at $36,066,000 after acquiring an additional 1,129 shares in the last quarter. Nicola Wealth Management LTD. boosted its stake in UnitedHealth Group by 2.2% in the first quarter. Nicola Wealth Management LTD. now owns 46,400 shares of the healthcare conglomerate’s stock valued at $24,302,000 after acquiring an additional 1,000 shares in the last quarter. Cim LLC boosted its stake in UnitedHealth Group by 1.2% in the first quarter. Cim LLC now owns 38,519 shares of the healthcare conglomerate’s stock valued at $20,174,000 after acquiring an additional 467 shares in the last quarter. Finally, Osterweis Capital Management Inc. raised its holdings in shares of UnitedHealth Group by 25.5% in the first quarter. Osterweis Capital Management Inc. now owns 85,563 shares of the healthcare conglomerate’s stock worth $44,814,000 after buying an additional 17,390 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.